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the tendency to bleed in the brain. We present a patient with progressive impairment of short-
term memory and apathy. Multiple hemorrhagic metastatic tumors in both cerebral hemi-
spheres were found on image examination. Chest computed tomography (CT) showed sus-
pected bronchogenic carcinoma. The left frontal brain tumor was removed, and pulmonary
giant cell cancer was proved by pathology. Unfortunately, intracerebral hemorrhages in
different locations were found to increase in the following brain computed tomography. A sec-
ond and a third brain tumor excision were performed. Pathology showed the same metastatic
giant cell carcinoma. The clinical course rapidly deteriorated, and the patient’s survival dura-
tion was about 11 months. This rare case provides us a unique clinical behavior of bleeding ten-
dency, rapid growth, and aggressive characters of this metastatic pulmonary giant cell cancer.
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Common causes of spontaneous intracerebral hemorrhage
(ICH) include hypertension, advanced age, leukoaraiosis,
prior ICH, renal failure, use of anticoagulant drugs, cere-
bral amyloid angiopathy, and tumor. Tumor-related ICH is
relatively uncommon. Although any brain tumor can bleed,
tumoral ICH is usually associated with malignancies. The
leading causes of tumor-related ICH are metastases of
extracranial origin (36%), followed by glioblastoma multi-
forme (30%).1
The lungs are the most common sources of brain metas-
tases in adults. Pulmonary giant cell carcinoma is one of the
rare histological subtypes with pleomorphic, sarcomatous
elements and has a poor prognosis because surgery, irradi-
ation, and chemotherapy are ineffective. Here, we report a
patient with pulmonary giant cell carcinoma that metasta-
sized to the brain, presenting as a case of repeated ICHs.
2. Case report
A 58-year-old male was admitted to our ward due to pro-
gressively worsening short-term memory, sluggish move-
ment, and a reticent state, with apathy having developed
within the past 2 weeks. Limb muscle power, deep tendon
reflex, sensation, and cranial nerve examination were
normal.
Laboratory examination revealed normal coagulation
function and platelet count with leukocytosis (18,930/mL).
The tumor markers of carcinoembryonic antigen (CEA)
(4.93 ng/ml), alpha-fetoprotein (AFP) (2.05 IU/ml), pros-
tate-specific antigen (PSA) (0.68 ng/ml), carbohydrate an-
tigen 199 (CA199) (<15.0 U/ml), and carbohydrate antigen
153 (CA153) (<15.0 U/ml) were all within the normal range.
Brain computed tomography (CT) showed multiple he-
matomas with perifocal edema in both cerebral hemi-
spheres. We considered hemorrhagic brain tumors. A right
infrahilar tumor was found on chest radiography (Fig. 1A). A
subsequent chest CT showed suspected bronchogenicFigure 1 (A) Chest radiography shows a right infrahilar tumor m
chogenic carcinoma in the right lower lobe with mediastinal metacarcinoma in the right lower lobe, with mediastinal meta-
static lymphadenopathy as well as metastases to the left
adrenal gland and T11 vertebrae (Fig. 1B). Bronchoscopy
was omitted because of the patient’s refusal. Besides,
multiple hemorrhagic tumors in both frontal lobes, the right
temporal lobe, and the right parietal lobe with perifocal
edema and mass effect were found using brain magnetic
resonance imaging (Fig. 2A and B). We considered that it
was a case of lung cancer with brain metastases.
On August 10, the patient underwent craniotomy and
left frontal tumor removal under a microscope. Tumor ne-
crosis with hematoma was found during operation.
Microscopic features of this tumor were discohesive
sheets of malignant giant cells with abundant eosinophilic
cytoplasm. Most cells were uninucleated, but a few multi-
nucleated cells were also present. There was prominent
emperipolesis with numerous neutrophils within the cyto-
plasm of multiple tumor cells (Fig. 3A and B). Immunohis-
tochemical study demonstrated cytokeratin 7 (þ),
cytokeratin 20 (), thyroid transcription factor 1 (þ), glial
fibrillary acidic protein (), and vimentin (þ) for tumor cells
(Fig. 3CeF). Based on the histopathology and immunohis-
tochemical study, the findings were considered consistent
with metastatic giant cell carcinoma from the lung.
Unfortunately, ICHs in different locations were found to
increase in the following brain CT performed on August 21
(Fig. 2C) and August 28 (Fig. 2D). Systemic coagulopathy
was excluded as the cause of ICH progression on account of
normal coagulation function and platelet count. The pa-
tient had second and third craniotomies and tumor
removal. Pathology showed the same metastatic giant cell
carcinoma from the lung.
The patient was finally discharged with a Glasgow
Outcome Scale score of 4 (able to live independently, but
unable to return to work). At the outpatient department,
the patient received the scheduled adjuvant whole-brain
radiotherapy twice (one was 1250 cGy in 5 fractions daily
and the other was 2500 cGy in 10 fractions daily) and
chemotherapy with gefitinib (Iressa) for about 1 month.
Survival duration was about 11 months.ass. (B) Chest computed tomography shows suspected bron-
static lymphadenopathy.
Figure 2 Brain magnetic resonance images show (A, B) multiple hemorrhagic tumors in both frontal lobes, right temporal lobe,
and right parietal lobe with perifocal edema and mass effect. Brain computed tomography images reveal that intracerebral
hemorrhages in the (C) right temporal lobe and (D) right parietal lobe were enlarged at a later time.
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Causes of ICH in cancer patients are multiple, such as
coagulation disorders, complications of anticancer treat-
ment, hypertension, and cirrhosis. We should exclude these
factors prior to defining tumor-related ICH.
The frequency of ICH in patients with intracranial neo-
plasms is 2e3%.1 The frequency of tumor-related ICH
among all ICH presentations is 7.2%.1 The frequency of ICH
as the initial clinical presentation of intracranial neoplasms
has been reported to be between 9% and 42%.1
Tumor-related ICH shows distinct characteristics in image
studies. It should be suspected if the ICH has surrounding
edema, an enhanced solid mass within or near the ICH, a
high- or low-density neoplastic core, or small, multifocal
clots usually at themargin of the tumor.1,2 It is often found in
an atypical location, e.g., subcortical region, regions close to
duralmembranes such as the falx or the tentorium, or regions
close to major cerebral veins or sinuses.1
In general, any type of intracranial neoplasm can cause
ICH; however, the frequency varies widely among different
tumor types.1 Naturally, high-grade malignancy, rapidgrowth, and highly vascularized neoplasms with an irregular
and fragile vascular architecture are most frequently
associated with ICH.1
Various theories for the etiology of intratumoral hem-
orrhage have been proposed previously: endothelial pro-
liferation with vascular obliteration, vessel compression
and/or distortion due to rapid tumor growth, vessel ne-
crosis, invasion of vessel walls by the tumor, and increased
venous pressure associated with increased intracranial
pressure.3
For metastatic hemorrhagic intracranial tumors, bron-
chogenic carcinoma, choriocarcinoma, malignant mela-
noma, and renal cell carcinoma are the most common
histologic types. Lung cancer can be classified into two
types: small-cell lung carcinoma and non-small-cell lung
carcinoma (NSCLC). The three main subtypes of NSCLC are
adenocarcinoma, squamous-cell carcinoma, and large-cell
carcinoma. Pulmonary giant cell carcinoma is classified as a
variant of large-cell carcinoma, regarded as one type of
sarcomatoid carcinoma.4 It is a rare histologic subtype and
has been reported to have a poor prognosis because sur-
gery, irradiation, and chemotherapy are not usually
Figure 3 Microscopy shows (A, B) hemorrhagic brain tissue and highly pleomorphic, discohesive multi- or mononucleated bizarre
giant tumor cells (white arrows), with inflammatory cells (black arrow) penetrating into the tumor cells. Immunohistochemical
study revealed (C) CK7(þ), (D) CK20(), (E) TTF-1(þ), and (F) GFAP() and vimentin (þ) for tumor cells. From CK7(þ), CK20(),
and TTF-1(þ), we can deduce that the origin of the metastatic giant cell carcinoma is the lung. CK Z cytokeratin; GFAP Z glial
fibrillary acidic protein; TTF Z thyroid transcription factor.
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metastatic at the time of diagnosis.
All sarcomatoid carcinomas occur in older adults, with a
median age of 60e70 years (range: 30e85 years), have a
strong male predominance, and are associated with a high
frequency of smoking.4 Koss et al5 reported a 5-year sur-
vival rate in 21.3% of patients. A median survival of 9e12
months has been reported in patients who underwent
curative surgery.6
Brain metastases occur in approximately 30% of patients
with metastatic NSCLC, who have a median survival of 6
months despite the effectiveness of radiotherapy.7 In
metastatic NSCLC patients, the incidence of spontaneous
ICH appears to be higher in those with brain metastases
(1.17%) than in those without (0.30%), but was very low in
both groups, without a statistically significant difference.7
Arai et al8 showed giant cell carcinoma to have the
fastest doubling time among all lung cancers (67.5 days). A
rapid growth with an early hematogenous spread may allowICH to be discovered prior to the detection of lung cancer.
More rapidly growing tumors show a tendency for a poorer
prognosis and a tendency to cause ICH. Hagihara et al also
reported a case of simultaneous ICH due to multiple met-
astatic lesions of pulmonary giant cell carcinoma.9 Both of
the two cases showed equally strong tendencies to bleed.
In the case reported by Hagihara et al,9 intracerebral
multiple metastases were detected with hemorrhage, but
the primary pulmonary giant cell cancer showed no hem-
orrhaging. This same feature was also noted in our study,
implying that the same tumor type does not produce the
same result in different organs. The brain may have a
stronger bleeding tendency than the lung.
Koenig et al10 reported a case of recurrent hemorrhagic
strokes associated with paraneoplastic disseminated intra-
vascular coagulation due to occult large cell carcinoma. In
our patient, although we did not find any evidence of
disseminated intravascular coagulation, we could not
ignore this potential problem.
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within different metastatic locations is rare. Progression of
metastatic tumors with necrosis of vessels may be the main
predisposing factors for the bleeding tendency of this met-
astatic tumor. Paraneoplastic phenomena such as a hyper-
coagulable state with venous thrombosis and increased
venous pressure leading to the rupture of a venulemight play
a role in the repeated ICHs of the metastatic tumors.
4. Conclusions
Pulmonary giant cell cancer is a malignant, aggressive, and
rare neoplasm. It has the tendency to bleed in the brain.
The characteristics of rapid growth and easy bleeding with
early hematogenous spread may allow ICH to be discovered
prior to the detection of lung cancer, as in the present case.
More frequent brain CT scans during the follow-up of these
patients may be necessary. Further study of detailed fac-
tors affecting tumor bleeding requires more cases and an-
imal model simulation.
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